When we considered in our cancer group the presence of cachexia, we observed a greater expression of ATGL and HSL compared to controls and this was confirmed when comparing non-cachectic patients with controls, whereas no difference was present between cachectic and non-cachectic patients. The gene discussed is PNPLA2; the disease is Cachexia.